(Investorideas.com Newswire) a go-to investing platform, releases an industry snapshot looking at advancements in novel immunotherapeutics, featuring Aethlon Medical, Inc.(Nasdaq:AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®, an extracorporeal device for oncology and other indications Novel immunotherapeutics have transformed oncology, moving away from broad, non-specific treatments toward highly personalized strategies that harness the patient's immune ...

Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review (Investorideas.com Newswire) a leading investment platform for retail investors reports breaking Medical Tech Stock news for Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company develop ...

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review Accessibility StatementSkip Navigation About the Hemopurifier® The Aethlon Hemopurifier is an investigational medical device designed to remove enveloped viruses and tumor-derived EVs from circulation. It is used extracorporeally with a blood pump and combines plasma separation, size exclusion, and affinity binding using a plant lectin resin that targets mannose-rich surfaces found on EVs and viruses. EV ...